EdenTree Asset Management’s Pfizer PFE Stock Holding History

EdenTree Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Hold	50,000	–	–	0.37%	53
2026 Q1	$1.4M	Hold	50,000	–	–	0.42%	48
2025 Q4	$1.25M	Hold	50,000	–	–	0.38%	48
2025 Q3	$1.27M	Hold	50,000	–	–	0.31%	47
2025 Q2	$1.21M	Hold	50,000	–	–	0.34%	48
2025 Q1	$1.27M	Hold	50,000	–	–	0.43%	48
2024 Q4	$1.33M	Hold	50,000	–	–	0.39%	53
2024 Q3	$1.45M	Hold	50,000	–	–	0.42%	47
2024 Q2	$1.4M	Hold	50,000	–	–	0.44%	41
2024 Q1	$1.39M	Hold	50,000	–	–	0.44%	41
2023 Q4	$1.44M	Sell	50,000 -60,559	-55%	-$1.83M	0.45%	44
2023 Q3	$3.67M	Hold	110,559	–	–	1.44%	24
2023 Q2	$4.05M	Buy	+110,559	New	+$4.3M	1.39%	25

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EdenTree Asset Management's PFE Position: Q2 2026 in Review

EdenTree Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 50,000 shares worth $1.2M. The position accounts for 0.37% of the portfolio, ranked #53.

EdenTree Asset Management first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.05M in Q2 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

EdenTree Asset Management held 50,000 shares of Pfizer worth $1.2M as of Q2 2026.
EdenTree Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.37% of EdenTree Asset Management's portfolio in Q2 2026, its #53 holding.
EdenTree Asset Management first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
EdenTree Asset Management's Pfizer position peaked at $4.05M in Q2 2023.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on EdenTree Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.